Patents

Humana Mailing More Than 1 Million Home Screening Kits to Increase Access to Preventive Care During COVID-19 Pandemic

Humana Mailing More Than 1 Million Home Screening Kits to Increase Access to Preventive Care During COVID-19 Pandemic

July 23, 2020 at 8:00 AM EDT

Move Triples the Number of Screening Kits Sent to Members

LOUISVILLE, Ky.--(BUSINESS WIRE)--Jul. 23, 2020-- Humana Inc. (NYSE: HUM) today announced that the company will mail more than 1 million in-home preventive care screening kits to members in 2020, helping increase access to routine screenings that many members have put off during the pandemic. Humana’s new initiative, which triples the number of screening kits sent to members, comes as many people have postponed all but the most necessary health procedures during COVID-19, limiting doctors’ appointments and emergency room visits.

“Because of the pandemic, many of our members – who are primarily seniors – have not been comfortable leaving their homes for routine health care,” said Dr. William Shrank, Chief Medical Officer at Humana. “Now more than ever, proactive, preventive care can be lifesaving and life-changing for our members. Many interactions with health care providers can be conducted virtually, and we encourage telehealth whenever possible. However, patients and doctors should work together to determine when in-person visits are needed, and we are taking every precaution to make sure those visits are safe and that our members have confidence to make the best decisions for their health. During these complex times, patients should not be distancing themselves from their doctors.”

Humana’s in-home screenings can help members identify complications related to diabetes and colon cancer early, which can help improve health outcomes and reduce costs. For example, in 2018, Humana member Leo Kovel completed an in-home test and was notified of an abnormal result. A colonoscopy discovered Leo had colon cancer, but after a successful surgery, he is now cancer-free.

Humana’s push to deliver in-home tests will focus particularly on members in need of colorectal cancer screening and diabetic condition management. They are being provided at no additional cost to Medicare Advantage members who are eligible for the test. In addition, eligible Medicaid members will receive the diabetic management test kits. This latest effort, which runs from June to September, builds on the company’s commitment to proactively mail easy-to-use colorectal cancer screening and diabetic management kits to qualifying members’ homes to identify cases of colon cancer earlier or to assess a patient's diabetes management to tailor therapy and help reduce complications of the disease. Members with questions should call the toll free customer service telephone number on the back of their Humana ID card.

During COVID-19, Humana has taken a number of unprecedented steps to support members, including eliminating out-of-pocket costs for primary care office visits so that Medicare Advantage members can reconnect with their health care providers and extending telehealth cost share waivers for all telehealth visits – primary care and specialty, including behavioral health, for participating/in-network providers through 2020.

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

● Annual reports to stockholders

Securities and Exchange Commission filings

● Most recent investor conference presentations

● Quarterly earnings news releases and conference calls

● Calendar of events

● Corporate Governance information

Mark Mathis
Humana Corporate Communications
312-441-5010
mmathis@humana.com

Source: Humana Inc.